2007 年国际基因组学大会--基因组学及测序技术新进展

Website:http://www.genomeconference2007.com/en/

New breakthroughs in genomics and sequencing technology have been made since the 2006 International Conference on Genomics (ICG) held in Hangzhou, China. Recent discoveries from the international research consortium ENCODE has reshaped our understanding of how the human genome functions. These findings include the discovery that the majority of the DNA in the human genome is transcribed into RNA, and that these transcripts extensively overlap one another. The data also indicates that the human genome contains very little unused sequences and is a complex interwoven network in which genes are just one of many types of DNA sequences that have a functional impact. These new discoveries will drive the continued development of accurate, cost-effective and high-throughput DNA sequencing technologies to decipher the functions of the complex genome for applications in clinical medicine and health care. The new DNA sequencing technologies will also serve as the impetus for investigations in comparative genomics, metagenomics and the Cancer Genome Project.

The 2007 ICG will focus on new developments in genomics and genome technology. Complementary to Sanger sequencing, the newly-developed DNA sequencing systems have already found wide applications in genome biology, ranging from whole genome sequencing to tag sequencing for the investigation of gene regulation to digital gene expression to discover rare and important genes that are responsible for specific biological functions and processes. More than 200 leading scientists in genome science and technology from around the world will be gathered in Shenzhen City to stimulate further development of this dynamic field for the benefit of our environment and global population. As one of the fastest growing cities in the world, Shenzhen is a particularly inspiring site for this conference because its rapid development mirrors that of genome technology in the 21^st century. We welcome you all to the 2007 ICG in Shenzhen!

Academic Committee

Chairman:

Church, George Harvard University, USA

Ju, Jingyue Columbia University, USA

Yang, Huanming Beijing Institute of Genomics, CAS, Beijing, China

Invited Speakers

Smith, Hamilton Nobel Laureate; Scientific Director, Institute for Biological Energy

Alternatives, J. Craig Venter Institute, USA

Brent, Roger President and Research Director, Molecular Sciences Institute, USA

Cantor, Charles Funding Director of the Human Genome Center, Lawrence Berkeley National Laboratory; Chief Scientific Officer, Sequenom Inc., USA

Gilliam, Conrad Professor and Chair of Human Genetics, University of Chicago, USA

Green, Eric Director, Division of Intramural Research; Chief of Genome Technology; Director of the NIH Intramural Sequencing Center, NIH, USA

Grills, George Director of Advanced Technology Assessment, Cornell University, USA

Hardin, Susan Founder, President and CEO, VisiGen Biotechnologies Inc. USA

Lizardi, Paul Professor of Pathology, Molecular Biophysics and Biochemistry

Yale University, USA

Mishra, Bhubaneswar Professor of Cell Biology, New York University School of Medicine, USA

Schloss, Jeffery Program Director of Genome Technology Development, NHGRI/NIH, Bethesda, USA

Registration fees